250
Views
5
CrossRef citations to date
0
Altmetric
Review

Infective endocarditis by Acinetobacter species: a systematic review

ORCID Icon, &
Pages 203-215 | Received 04 Jun 2020, Accepted 06 Aug 2020, Published online: 02 Sep 2020

References

  • Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside. World J Clin Cases. 2014;2(12):787–814.
  • Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents. 2008;32(2):106–19.
  • von Graevenitz A. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria. In: Murray PR, Baron JE, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington, DC: ASM Press; 1995. p. 520–32.
  • Hanlon GW. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol. 2005;41(5):375–8.
  • Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991;29(2):277–82.
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–82.
  • Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30(1):409–47.
  • Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M, et al. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect. 2006;64(3):282–7.
  • Sunenshine RH, Wright M-O, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerging Infect Dis. 2007;13(1):97–103.
  • Kwon KT, Oh WS, Song J-H, Chang H-H, Jung S-I, Kim S-W, Ryu SY, Heo ST, Jung DS, Rhee J-Y, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother. 2007;59(3):525–30.
  • Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. JAMA. 2018;320(1):72–83.
  • Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.
  • Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, et al. Non-HACEK gram-negative Bacillus endocarditis. Ann Intern Med. 2007;147(12):829–35.
  • Lemos EV, de la Hoz FP, Einarson TR, McGhan WF, Quevedo E, Castañeda C, Kawai K. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014;20(5):416–23.
  • Lee C-R, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha C-J, Jeong BC, Lee SH. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.
  • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
  • Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium; January 2012; pp. 819–24.
  • Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.
  • Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
  • Kanda T, Nakano A, Ohshima S, Yuasa K, Watanabe T, Suzuki T, Murata K. Native valve endocarditis caused by Acinetobacter calcoaceticus subspecies lwoffi. Jpn Circ J. 1990;54(12):1563–5.
  • Laganà P, Melcarne L, Delia S. Acinetobacter baumannii and endocarditis, rare complication but important clinical relevance. Int J Cardiol. 2015;187:678–9.
  • Noble RC, Cooper RM, Jarvis AL, Caples PL, Todd EP. Trimethoprim-sulfamethoxazole therapy for infective endocarditis. South Med J. 1981;74(11):1299–303.
  • Minzter A. Human infection caused by the Mimeae organisms; report of a case of a presumably healed bacterial endocarditis due to Herellea vaginicola. AMA Arch Intern Med. 1956;98(3):352–5.
  • Olut AI, Erkek E. Early prosthetic valve endocarditis due to Acinetobacter baumannii: a case report and brief review of the literature. Scand J Infect Dis. 2005;37(11–12):919–21.
  • Chen Q, Cao H, Lu H, Qiu ZH, He JJ. Bioprosthetic tricuspid valve endocarditis caused by Acinetobacter baumannii complex, a case report and brief review of the literature. J Cardiothorac Surg. 2015;10:149
  • Patel G, Perez F, Hujer AM, Rudin SD, Augustine JJ, Jacobs GH, Jacobs MR, Bonomo RA. Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient. Transpl Infect Dis. 2015;17(2):289–96.
  • Valero C, Fariñas MC, García Palomo D, Mazarrasa JC, González MJ. Endocarditis due to Acinetobacter lwoffi on native mitral valve. Int J Cardiol. 1999;69(1):97–9.
  • Tseng HW, Chen GJ, Lu CC, Pan SC, Chen YS, Chang SC. Aortic root abscess caused by multidrug-resistant Acinetobacter baumannii and treated with medical therapy only: a case report. J Microbiol Immunol Infect. 2018;51(3):417–8.
  • Kunhi M, Sanagar S, Jagadeesh N, Shankar B, Abraham A. Emergency cardiac double valve surgery in active infective endocarditis due to Acinetobacter baumannii with aortic root abscess in a patient with dialysis-dependent end-stage renal failure: a rare case report. J Surg Case Rep. 2016;2016(12):rjw168.
  • Tsai WC, Peng YS. Acinetobacter endocarditis in a chronic hemodialysis patient. Acta Nephrologica. 2012;26:155–8.
  • Richardson RL Jr. Mimeae septicemia. JAMA. 1969;207(9):1716–7.
  • Kumar SS, Vengadassalapathy L, Menon T. Prosthetic valve endocarditis caused by Acinetobacter baumannii complex. Indian J Pathol Microbiol. 2008;51(4):573.
  • Bhagan-Bruno S, Lather N, Fergus IV. Acinetobacter endocarditis presenting as a large right atrial mass: an atypical presentation. Echocardiography. 2010;27(4):E39–42.
  • Carlson DJ. Endocarditis caused by Herrellea. Report of a case, with postmortem observations. Am J Clin Pathol. 1963;40:54–7.
  • Gradon JD, Chapnick EK, Lutwick LI. Infective endocarditis of a native valve due to Acinetobacter: case report and review. Clin Infect Dis. 1992;14(5):1145–8.
  • Block PC, DeSanctis RW, Weinberg AN, Austen WG. Prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1970;60(4):540–8.
  • Castellanos Martínez E, Telenti Asensio M, Rodríguez Blanco VM, Rodríguez Suárez ML, Morena Torrico A, Cortina Llosa A. Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus. Infection. 1995;23(4):243–5.
  • Pal RB, Sujatha V, Kale VV. Acinetobacter calcoaceticus causing subacute bacterial endocarditis. Lancet. 1981;2(8241):313.
  • Buchanan TM. Mima polymorpha endocarditis: a patient with two artificial heart valves. South Med J. 1972;65:693.
  • Rizos I, Tsiodras S, Papathanasiou S, Rigopoulos A, Barbetseas J, Stefanadis C. Prosthetic valve endocarditis due to Acinetobacter spp: a rare case and literature review. Am J Med Sci. 2007;333(3):197–9.
  • Pearlman SA, Higgins S, Eppes S, Bhat AM, Klein JD. Infective endocarditis in the premature neonate. Clin Pediatr (Phila)). 1998;37(12):741–6.
  • Yu-Hsien L, Te-Li C, Chien-Pei C, Chen-Chi T. Nosocomial acinetobacter genomic species 13 TU endocarditis following an endoscopic procedure. Intern Med. 2008;47(8):799–802.
  • Pike RM, Schulze ML, McCullough M. Isolation of Mima polymorpha from a patient with subacute bacterial endocarditis. Am J Clin Pathol. 1951;21(11):1094–6.
  • Malik AS. Acinetobacter endocarditis in children: a case report and review of the literature. Infection. 1995;23(5):306–8.
  • Taboada M, Barbeito-Castiñeiras G, Almeida X, Caruezo V, Cereijo J, Naveira A. Unusual infective prosthetic valve endocarditis due to Pseudomonas monteilii and Acinetobacter nosocomialis with a fatal result. Rev Esp Anestesiol Reanim. 2019;66(9):487–9.
  • Mangoni E, Andini R, Agrusta F, Iossa D, Mattucci I, Bernardo M, Utili R. Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years. Eur J Intern Med. 2014;25(7):657–61.
  • Weinberger I, Davidson E, Rotenberg Z, Fuchs J, Agmon J. Prosthetic valve endocarditis caused by Acinetobacter calcoaceticus subsp. lwoffi. J Clin Microbiol. 1987;25(5):955–7.
  • Yeh TJ, Anabtawi IN, Cornett VE, White A, Stern WH, Ellison RG. Bacterial endocarditis following open-heart surgery. Ann Thorac Surg. 1967;3(1):29–36.
  • Hirsch SR, Koch ML. Herellea (bacterium anitratum) endocarditis. report of a case. JAMA. 1964;187:148–50.
  • Starakis I, Blikas A, Siagris D, Marangos M, Karatza C, Bassaris H. Prosthetic valve endocarditis caused by Acinetobacter lwoffi: a case report and review. Cardiol Rev. 2006;14(1):45–9.
  • King OH Jr, Copeland GD, Berton WM. Cardiovascular lesions of the mimeae organisms. Am J Med. 1963;35:241–50.
  • Thompson WR. H vaginicola endocarditis in a heroin addict. JAMA. 1971;215(6):982.
  • Murtaza K, Kashyap A, Arya S, Chellani H. Acinetobacter endocarditis in neonates: a rare organism for a rare age group disease. J Pediatr Infect Dis. 2016;11(1):013–4.
  • Ahmadi H, Boroumand MA, Anvari MS, Karimi A, Moshtaghi N. Left-sided endocarditis associated with multi-drug resistance Acinetobacter lwoffii. J Teh Univ Heart Ctr. 2009;4:189–92.
  • Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882–93.
  • Loubet P, Lescure F-X, Lepage L, Kirsch M, Armand-Lefevre L, Bouadma L, Lariven S, Duval X, Yazdanpanah Y, Joly V, et al. Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome. Infect Dis (Lond). 2015;47(12):889–95.
  • Veve MP, McCurry ED, Cooksey GE, Shorman MA. Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States. PLoS One. 2020;15(3):e0230199.
  • Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother. 2011;66(4):738–44.
  • Krzyściak P, Chmielarczyk A, Pobiega M, Romaniszyn D, Wójkowska-Mach J. Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility. APMIS. 2017;125(11):1017–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.